Microbot Medical (NASDAQ:MBOT) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Microbot Medical (NASDAQ:MBOT) issued its quarterly earnings results on Tuesday. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.02), Zacks reports.

Microbot Medical Stock Performance

NASDAQ MBOT traded down $0.01 on Tuesday, hitting $1.59. 759,689 shares of the stock were exchanged, compared to its average volume of 1,767,746. Microbot Medical has a 52-week low of $0.82 and a 52-week high of $3.38. The firm has a market capitalization of $55.24 million, a P/E ratio of -1.99 and a beta of 1.60. The stock has a fifty day moving average price of $1.75 and a two-hundred day moving average price of $1.30.

Wall Street Analyst Weigh In

Separately, HC Wainwright lifted their price objective on shares of Microbot Medical from $7.00 to $9.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.